BMSRI is ranked within the top five out of 94 universities submitted in the UK REF2014 panel in terms of research power in biomedical science.
Biomedical research at Ulster University’s BMSRI covers all levels of biomedicine from the molecular to the whole human including disease development, prevention, diagnosis and therapy. Significantly, in REF2014 our research environment was awarded an unprecedented 100% 4* (world-leading), 95% of our research impact was scored world leading (4*) and internationally excellent (3*) and 81% of research published papers were judged to be world leading and internationally excellent (4* and 3*).
The Biomedical Sciences Research Institute (BMSRI) specialises in the study of the biological mechanisms (especially those which relate to gene-nutrient interactions) associated with degenerative diseases – eg., cancer, diabetes, heart disease, osteoporosis and visual deterioration. Members of the Institute are conducting pioneering research in these areas, with a determination to investigate the underlying causes, diagnosis, treatment and prevention of human degenerative diseases.
Visit the BMSRI website – http://biomed.science.ulster.ac.uk/research-institute/
The BMSRI is also exploiting the remarkable opportunities made possible by recent molecular advances: revolutionary changes in biomedicine and biotechnology that will soon transform whole industries and economies, but which offer particular advantages in our field. The proper application of the results of our research can confidently be expected, over the next decade, to transform our understanding of human biology and pathology by giving us a real understanding of their very complex molecular aspects. The BMSRI is actively pursuing these goals by applying a range of rapidly developing techniques: bioimaging, systems biology, genomics, proteomics, transgenics etc., to a variety of problems in human health.